Short- and Medium-term Prognosis in Patients Hospitalized for COPD Exacerbation: The CODEX Index

Chest

Volumn 145, Issue 5, 2014, Pages 972-980

  Almagro, Pedro ^a   Soriano, Joan B ^b   Cabrera, Francisco J ^c   Boixeda, Ramon ^d   Alonso Ortiz, M Belen ^f   Barreiro, Bienvenido ^a   Diez Manglano, Jesus ^g   Murio, Cristina ^e   Heredia, Josep L ^a  

^a HOSPITAL MÚTUA DE TERRASSA   (Spain)

^b Laboratory of Microbial Pathogenesis   (Spain)

^c HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^d Hospital de Mataró   (United States)

^e Laboratorios Chiesi   (United States)

^f HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

^g HOSPITAL ROYO VILLANOVA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADO INDEX; AGE DISTRIBUTION; AGED; AIRWAY OBSTRUCTION; ARTICLE; BODEX INDEX; BODY MASS; CHARLSON COMORBIDITY INDEX; CHRONIC OBSTRUCTIVE LUNG DISEASE; CODEX INDEX; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DISEASE EXACERBATION; DOSE INDEX; FEMALE; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEDIUM TERM PROGNOSIS; MORTALITY RATE; MULTICENTER STUDY; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; SHORT TERM PROGNOSIS; SMOKING HABIT; SURVIVAL PREDICTION; VALIDATION STUDY; DISEASE COURSE; DYSPNEA; FOLLOW UP; HOSPITAL DISCHARGE; HOSPITAL PATIENT; MORTALITY; REPRODUCIBILITY; RETROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; SPAIN; SURVIVAL RATE; TIME;

AGED; AIRWAY OBSTRUCTION; DISEASE PROGRESSION; DYSPNEA; FEMALE; FOLLOW-UP STUDIES; HOSPITAL MORTALITY; HUMANS; INPATIENTS; MALE; PATIENT DISCHARGE; PATIENT READMISSION; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SPAIN; SURVIVAL RATE; TIME FACTORS;

EID: 84899799949     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.13-1328     Document Type: Article

References (35)

1. 1 Vos, T, Flaxman, AD, Naghavi, M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010 [published correction appears in Lancet. 2013;381(9867):628]. Lancet 380:9859 (2012), 2163–2196.
2. 2 Nishimura, K, Izumi, T, Tsukino, M, Oga, T, Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 121:5 (2002), 1434–1440.
3. 3 Soler-Cataluña, JJ, Martínez-García, MA, Román Sánchez, P, Salcedo, E, Navarro, M, Ochando, R, Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 60:11 (2005), 925–931.
4. 4 Vestbo, J, Hurd, SS, Agustí, AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 187:4 (2013), 347–365.
5. 5 Celli, BR, Cote, CG, Marin, JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 350:10 (2004), 1005–1012.
6. 6 Soler-Cataluña, JJ, Martínez-García, MA, Sánchez, LS, Tordera, MP, Sánchez, PR, Severe exacerbations and BODE index: two independent risk factors for death in male COPD patients. Respir Med 103:5 (2009), 692–699.
7. 7 Puhan, MA, Garcia-Aymerich, J, Frey, M, et al. Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index. Lancet 374:9691 (2009), 704–711.
8. 8 Puhan, MA, Hansel, NN, Sobradillo, P, et al. International COPD Cohorts Collaboration Working Group. Large-scale international validation of the ADO index in subjects with COPD: an individual subject data analysis of 10 cohorts. BMJ Open, 2(6), 2012 pii: e002152.
9. 9 Jones, RC, Donaldson, GC, Chavannes, NH, et al. Derivation and validation of a composite index of severity in chronic obstructive pulmonary disease: the DOSE Index. Am J Respir Crit Care Med 180:12 (2009), 1189–1195.
10. 10 Marin, JM, Alfageme, I, Almagro, P, et al. Multicomponent indices to predict survival in COPD: the COCOMICS study. Eur Respir J 42:2 (2013), 323–332.
11. 11 Almagro, P, Salvadó, M, Garcia-Vidal, C, et al. Recent improvement in long-term survival after a COPD hospitalisation. Thorax 65:4 (2010), 298–302.
12. 12 Erbas, B, Ullah, S, Hyndman, RJ, Scollo, M, Abramson, M, Forecasts of COPD mortality in Australia: 2006-2025. BMC Med Res Methodol, 12(1), 2012, 17.
13. 13 Almagro, P, Calbo, E, Ochoa de Echagüen, A, et al. Mortality after hospitalization for COPD. Chest 121:5 (2002), 1441–1448.
14. 14 Divo, M, Cote, C, de Torres, JP, et al. Comorbidities and risk of mortality in patients with COPD. Am J Respir Crit Care Med 186:2 (2012), 155–161 BODE Collaborative Group.
15. 15 Roberts, CM, Stone, RA, Lowe, D, Pursey, NA, Buckingham, RJ, Co-morbidities and 90-day outcomes in hospitalized COPD exacerbations. COPD 8:5 (2011), 354–361.
16. 16 Almagro, P, Cabrera, FJ, Diez, J, et al. Comorbidities and short-term prognosis in patients hospitalized for acute exacerbation of COPD: the EPOC en Servicios de medicina interna (ESMI) study. Chest 142:5 (2012), 1126–1133 Working Group on COPD, Spanish Society of Internal Medicine.
17. 17 Almagro, P, López, F, Cabrera, FJ, et al. Comorbidities in patients hospitalized due to chronic obstructive pulmonary disease. A comparative analysis of the ECCO and ESMI studies [in Spanish]. Rev Clin Esp 212:6 (2012), 281–286 Grupos de trabajo de EPOC y Paciente Pluripatológico y Edad Avanzada de la Sociedad Española de Medicina Interna.
18. 18 Charlson, ME, Pompei, P, Ales, KL, MacKenzie, CR, A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:5 (1987), 373–383.
19. 19 Sanjaume, M, Almagro, P, Rodríguez-Carballeira, M, Barreiro, B, Heredia, JL, Garau, J, Post-hospital mortality in patients re-admitted due to COPD. Utility of BODE index [in Spanish]. Rev Clin Esp 209:8 (2009), 364–370.
20. 20 DeLong, ER, DeLong, DM, Clarke-Pearson, DL, Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:3 (1988), 837–845.
21. 21 Seneff, MG, Wagner, DP, Wagner, RP, Zimmerman, JE, Knaus, WA, Hospital and 1-year survival of patients admitted to intensive care units with acute exacerbation of chronic obstructive pulmonary disease. JAMA 274:23 (1995), 1852–1857.
22. 22 Wildman, MJ, Sanderson, C, Groves, J, et al. Predicting mortality for patients with exacerbations of COPD and Asthma in the COPD and Asthma Outcome Study (CAOS). QJM 102:6 (2009), 389–399.
23. 23 Connors, AF Jr, Dawson, NV, Thomas, C, et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments). Am J Respir Crit Care Med 154:4 pt 1 (1996), 959–967.
24. 24 Steer, J, Gibson, J, Bourke, SC, The DECAF score: predicting hospital mortality in exacerbations of chronic obstructive pulmonary disease. Thorax 67:11 (2012), 970–976.
25. 25 Vestbo, J, Edwards, LD, Scanlon, PD, et al. Changes in forced expiratory volume in 1 second over time in COPD. N Engl J Med 365:13 (2011), 1184–1192 ECLIPSE Investigators.
26. 26 Suissa, S, Dell'Aniello, S, Ernst, P, Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality. Thorax 67:11 (2012), 957–963.
27. 27 Cote, CG, Celli, BR, Pulmonary rehabilitation and the BODE index in COPD. Eur Respir J 26:4 (2005), 630–636.
28. 28 Sundh, J, Janson, C, Lisspers, K, Ställberg, B, Montgomery, S, The Dyspnoea, Obstruction, Smoking, Exacerbation (DOSE) index is predictive of mortality in COPD. Prim Care Respir J 21:3 (2012), 295–301.
29. 29 Austin, PC, Stanbrook, MB, Anderson, GM, Newman, A, Gershon, AS, Comparative ability of comorbidity classification methods for administrative data to predict outcomes in patients with chronic obstructive pulmonary disease. Ann Epidemiol 22:12 (2012), 881–887.
30. 30 Charlson, M, Szatrowski, TP, Peterson, J, Gold, J, Validation of a combined comorbidity index. J Clin Epidemiol 47:11 (1994), 1245–1251.
31. 31 Lainscak, M, von Haehling, S, Doehner, W, et al. Body mass index and prognosis in patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease. J Cachexia Sarcopenia Muscle 2:2 (2011), 81–86.
32. 32 Simon-Tuval, T, Scharf, SM, Maimon, N, Bernhard-Scharf, BJ, Reuveni, H, Tarasiuk, A, Determinants of elevated healthcare utilization in patients with COPD. Respir Res, 12, 2011, 7 10.1186/1465-9921-12-7.
33. 33 Calverley, PM, Anderson, JA, Celli, B, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 356:8 (2007), 775–789 TORCH investigators.
34. 34 Slenter, RH, Sprooten, RT, Kotz, D, Wesseling, G, Wouters, EF, Rohde, GG, Predictors of 1-year mortality at hospital admission for acute exacerbations of chronic obstructive pulmonary disease. Respiration 85:1 (2013), 15–26.
35. 35 Pozo-Rodríguez, F, López-Campos, JL, Alvarez-Martínez, CJ, et al. Clinical audit of COPD patients requiring hospital admissions in Spain: AUDIPOC study. PLoS ONE, 7(7), 2012, e42156 AUDIPOC Study Group.